Recent Updates
Recently added Catalysts
EPRX Positive Sentiment Score: 75/100

FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Company Eupraxia Pharmaceuticals Inc. (the Company ) 201-2067 Cadboro Bay Rd. Victoria, British Columbia Canada, V8R 5G4 Item 2: Date of Material Change

Friday, April 5, 2024 1 min read
Key Takeaway: Eupraxia Pharmaceuticals Inc. announced on April 5, 2024, that its common shares will begin trading on the Nasdaq Capital Market under the ticker symbol EPRX. This move is aimed at increasing the company's market presence and visibility. The shares will continue to be listed on the Toronto Stock Exchange under the same ticker. The news release was disseminated through Globe Newswire.

Market Sentiment Analysis

POSITIVE FACTORS

  • Eupraxia Pharmaceuticals will begin trading on the Nasdaq, indicating growth.
  • The dual listing on both Nasdaq and the Toronto Stock Exchange enhances visibility.
  • The announcement suggests confidence in the company's market potential.

Full Press Release Details

MATERIAL CHANGE REPORT
Eupraxia Pharmaceuticals Inc. (the Company )
201-2067 Cadboro Bay Rd.
Victoria, British Columbia
A news release announcing the material change was issued on April 5, 2024 through Globe Newswire and a copy was subsequently filed on
On April 5, 2024, the Company announced that trading of the Company s common shares would begin on the Nasdaq Capital Market
( Nasdaq ), under the ticker symbol EPRX .
On April 5, 2024, the Company announced that trading of the Company s common shares would begin on the Nasdaq, under the ticker
symbol EPRX . The Company s shares also continue to trade on the Toronto Stock Exchange under the ticker symbol EPRX .
For further information, please contact Bruce Cousins, President and Chief Financial Officer of the Company at

Frequently Asked Questions

What major announcement did Eupraxia Pharmaceuticals make?

Eupraxia Pharmaceuticals announced that its common shares will begin trading on the Nasdaq.

When will EPRX trade on the Nasdaq?

Trading of the company's common shares on the Nasdaq began on April 5, 2024.

Is Eupraxia Pharmaceuticals listed on any other stock exchanges?

Yes, Eupraxia's shares continue to trade on the Toronto Stock Exchange.

How can I contact Eupraxia Pharmaceuticals for more info?

Contact Bruce Cousins, the President and CFO, for further information.

Tags: EPRX Viatris Investor Conferences Healthcare Eupraxia Pharmaceuticals Nasdaq stock exchange Victoria
Last updated: Apr 5, 2024